Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NHI
NHI logo

NHI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy National Health Investors Inc (NHI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
70.430
1 Day change
3.09%
52 Week Range
91.380
Analysis Updated At
2026/06/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

NHI is not a strong buy right now for a beginner long-term investor with $50,000-$100,000, even though it is trading slightly up pre-market. The technical setup is still bearish, analyst sentiment is mixed-to-positive, and options flow is bearish. My clear view is to hold off on buying today and wait for a cleaner confirmation of trend reversal.

Technical Analysis

NHI is in a weak technical position. MACD histogram is -0.512 and still expanding lower, showing downside momentum. RSI_6 at 10.874 indicates the stock is extremely oversold, which can support a bounce, but oversold alone is not enough to justify a buy when the broader trend remains bearish. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a downtrend. Price is near support at 69.295 and below the pivot at 72.8, with the current pre-market price at 69.17 just under S1. Short-term probability data also points to mild downside over the next day, week, and month.

Options Data

Neutral
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options positioning is mixed on open interest, but very bearish in today’s activity. The open interest put-call ratio of 0.96 is roughly balanced, while the option volume put-call ratio of 5.67 shows heavy put buying relative to calls. Put volume is 17 versus call volume of 3, suggesting traders are positioning defensively. Implied volatility is elevated at 32.27 with IV percentile 81.75, which also reflects active demand for protection.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
5

Positive Catalysts

  • The stock is deeply oversold technically, which could allow for a rebound if support holds.

Neutral/Negative Catalysts

  • There was no news in the recent week, so there is no fresh event-driven catalyst. The technical trend remains bearish, and the options market is leaning bearish through high put volume. Wells Fargo kept only an Equal Weight rating and noted uncertainty around the NHC lease and rent reset impact. Hedge funds and insiders are neutral, and there is no recent congress or influential figure trading data to support the name.

Financial Performance

No latest quarter financial snapshot was available because the provided financial data returned an error. Since the latest quarter season is not provided, I cannot responsibly assess quarter-over-quarter revenue, FFO, or occupancy trends from the data given.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment has improved modestly. On 2026-03-12, Truist raised its target to 92 from 85 and kept a Buy rating, saying NHI should benefit from stronger occupancy fundamentals. On 2026-03-27, Wells Fargo raised its target to 86 from 85 but kept an Equal Weight rating, implying more caution and noting potential FFO estimate inflation around the NHC lease/rent reset issue. Overall, Wall Street looks somewhat constructive but not unanimously bullish: the pros are improving fundamentals and higher targets, while the cons are lease uncertainty and only moderate conviction from some analysts.

Wall Street analysts forecast NHI stock price to rise
7 Analyst Rating
Wall Street analysts forecast NHI stock price to rise
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 68.320
sliders
Low
77
Averages
85.43
High
90
Current: 68.320
sliders
Low
77
Averages
85.43
High
90
Wells Fargo
Equal Weight
maintain
$85 -> $86
AI Analysis
2026-03-27
Reason
Wells Fargo
Price Target
$85 -> $86
AI Analysis
2026-03-27
maintain
Equal Weight
Reason
Wells Fargo raised the firm's price target on National Health Investors to $86 from $85 and keeps an Equal Weight rating on the shares. The firm notes the company entered a quiet period in on its NHC lease, and it expects a resolution before Q1 earnings. Based on Wells' analysis and conversations with investors, the firm thinks buy-side estimates may have overstated the FFO impact from a rent reset.
Truist
Buy
maintain
$85 -> $92
2026-03-12
Reason
Truist
Price Target
$85 -> $92
2026-03-12
maintain
Buy
Reason
Truist raised the firm's price target on National Health Investors to $92 from $85 and keeps a Buy rating on the shares. The company's senior housing operating portfolio disappointed in the second half of the year, but the firm expects National Health to ride favorable fundamentals to higher occupancy going forward, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NHI
Unlock Now

People Also Watch